BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3191287)

  • 1. Intestinal absorption of oyster shell electrolysate.
    Fujita T; Fukase M; Nakada M; Koishi M
    Bone Miner; 1988 Sep; 4(4):321-7. PubMed ID: 3191287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The experimental study on absorption and utilization of calcium from oyster shell powder mixed with fruit juice].
    Xu G; Zhao X; Lin X; Yu H
    Wei Sheng Yan Jiu; 1997 Sep; 26(5):333-6. PubMed ID: 10325650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Metabolism and utilization of calcium derived from hydrolysed oyster shell in rats].
    Shen X; Lu R; Wu M
    Zhonghua Yu Fang Yi Xue Za Zhi; 1996 Mar; 30(2):91-3. PubMed ID: 8758856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral magnesium load test for the assessment of intestinal magnesium absorption. Application in control subjects, absorptive hypercalciuria, primary hyperparathyroidism, and hypoparathyroidism.
    Nicar MJ; Pak CY
    Miner Electrolyte Metab; 1982 Jul; 8(1):44-51. PubMed ID: 6897741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioavailability of calcium from calcium carbonate, DL-calcium lactate, L-calcium lactate and powdered oyster shell calcium in vitamin D-deficient or -replete rats.
    Tsugawa N; Okano T; Higashino R; Kimura T; Oshio Y; Teraoka Y; Igarashi C; Ezawa I; Kobayashi T
    Biol Pharm Bull; 1995 May; 18(5):677-82. PubMed ID: 7492981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of daily calcium and vitamin D supplementation on parathyroid hormone secretion.
    Reginster JY; Zegels B; Lejeune E; Micheletti MC; Taquet AN; Albert A
    Gynecol Endocrinol; 2001 Feb; 15(1):56-62. PubMed ID: 11293926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement and meaning of calcium absorption.
    Nordin BE
    Gastroenterology; 1968 Feb; 54(2):294-301. PubMed ID: 5711911
    [No Abstract]   [Full Text] [Related]  

  • 9. Increase of bone mineral density by calcium supplement with oyster shell electrolysate.
    Fujita T; Fukase M; Miyamoto H; Matsumoto T; Ohue T
    Bone Miner; 1990 Oct; 11(1):85-91. PubMed ID: 2268740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On self-organized shell formation by bovine carbonic anhydrase II, and soluble protein extracted from regenerated shell.
    Lee SW; Park SB; Choi CS
    Micron; 2008 Dec; 39(8):1228-34. PubMed ID: 18501616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemocyte-mediated shell mineralization in the eastern oyster.
    Mount AS; Wheeler AP; Paradkar RP; Snider D
    Science; 2004 Apr; 304(5668):297-300. PubMed ID: 15073378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biologic effects of 1,25-dihydroxycholecalciferol (a highly active vitamin D metabolite) in acutely uremic rats.
    Wong RG; Norman AW; Reddy CR; Coburn JW
    J Clin Invest; 1972 May; 51(5):1287-91. PubMed ID: 4341503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of hypoparathyroid patients with chlorthalidone.
    Porter RH; Cox BG; Heaney D; Hostetter TH; Stinebaugh BJ; Suki WN
    N Engl J Med; 1978 Mar; 298(11):577-81. PubMed ID: 628374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative bioavailability of calcium from calcium formate, calcium citrate, and calcium carbonate.
    Hanzlik RP; Fowler SC; Fisher DH
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1217-22. PubMed ID: 15734899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of 1,25-dihydroxycholecalciferol on intestinal calcium transport in cortisone-treated rats.
    Favus MJ; Walling MW; Kimberg DV
    J Clin Invest; 1973 Jul; 52(7):1680-5. PubMed ID: 4718960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sevelamer controls parathyroid hormone-induced bone disease as efficiently as calcium carbonate without increasing serum calcium levels during therapy with active vitamin D sterols.
    Salusky IB; Goodman WG; Sahney S; Gales B; Perilloux A; Wang HJ; Elashoff RM; Jüppner H
    J Am Soc Nephrol; 2005 Aug; 16(8):2501-8. PubMed ID: 15944337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral vitamin D supplementation reduces the incidence of eucalcemic PTH elevation after surgery for primary hyperparathyroidism.
    Beyer TD; Solorzano CC; Prinz RA; Babu A; Nilubol N; Patel S
    Surgery; 2007 Jun; 141(6):777-83. PubMed ID: 17560254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical effects of calcium and vitamin D supplementation in elderly, institutionalized, vitamin D-deficient patients.
    Chapuy MC; Chapuy P; Thomas JL; Hazard MC; Meunier PJ
    Rev Rhum Engl Ed; 1996 Feb; 63(2):135-40. PubMed ID: 8689285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postprandial metabolic responses to milk enriched with milk calcium are different from responses to milk enriched with calcium carbonate.
    Green JH; Booth C; Bunning R
    Asia Pac J Clin Nutr; 2003; 12(1):109-19. PubMed ID: 12737020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absorption of phosphate in the jejunum of patients with chronic renal failure before and after correction of vitamin D deficiency.
    Davis GR; Zerwekh JE; Parker TF; Krejs GJ; Pak CY; Fordtran JS
    Gastroenterology; 1983 Oct; 85(4):908-16. PubMed ID: 6688402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.